Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Glyx-13 Peptide
2. Tppt-amide
1. 117928-94-6
2. Tppt-amide
3. Glyx 13
4. Glyx13
5. Glyx-13
6. Rapastinelum
7. L-threoninamide, L-threonyl-l-prolyl-l-prolyl-
8. Glyx-13 Trifluoroacetate
9. 6a1x56b95e
10. (2s)-1-[(2s)-1-[(2s,3r)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]pyrrolidine-2-carboxamide
11. Glyx-13 Peptide
12. Rapastinel [usan:inn]
13. Unii-6a1x56b95e
14. (s)-n-((2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl)-1-((s)-1-((2s,3r)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide
15. Glyx13;rapastinel
16. Rapastinel(glyx-13)
17. Thr-pro-pro-thr-nh2
18. Rapastinel [inn]
19. Rapastinel [usan]
20. Rapastinel (glyx-13)
21. Rapastinel [who-dd]
22. Schembl1668190
23. Chembl3544917
24. Ex-a794
25. Dtxsid501030481
26. Mfcd12912477
27. S6907
28. Zinc71773625
29. Akos024457610
30. Cs-5507
31. Db11801
32. Ncgc00485669-01
33. Ac-32874
34. As-55920
35. Hy-16728
36. L-threonyl-l-prolyl-l-prolyl-l-threoninamide
37. Q5513673
38. (s)-1-(l-threonyl-l-prolyl)-n-((2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl)pyrrolidine-2-carboxamide
| Molecular Weight | 413.5 g/mol |
|---|---|
| Molecular Formula | C18H31N5O6 |
| XLogP3 | -2.8 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 413.22743373 g/mol |
| Monoisotopic Mass | 413.22743373 g/mol |
| Topological Polar Surface Area | 179 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 659 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Rapastinel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rapastinel, including repackagers and relabelers. The FDA regulates Rapastinel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rapastinel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rapastinel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rapastinel supplier is an individual or a company that provides Rapastinel active pharmaceutical ingredient (API) or Rapastinel finished formulations upon request. The Rapastinel suppliers may include Rapastinel API manufacturers, exporters, distributors and traders.
click here to find a list of Rapastinel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Rapastinel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rapastinel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rapastinel GMP manufacturer or Rapastinel GMP API supplier for your needs.
A Rapastinel CoA (Certificate of Analysis) is a formal document that attests to Rapastinel's compliance with Rapastinel specifications and serves as a tool for batch-level quality control.
Rapastinel CoA mostly includes findings from lab analyses of a specific batch. For each Rapastinel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rapastinel may be tested according to a variety of international standards, such as European Pharmacopoeia (Rapastinel EP), Rapastinel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rapastinel USP).
LOOKING FOR A SUPPLIER?
